SOX30 Inhibits Tumor Metastasis through Attenuating Wnt-Signaling via Transcriptional and Posttranslational Regulation of β-Catenin in Lung Cancer
- EBioMedicine. 2018 May;31:253-266. doi: 10.1016/j.ebiom.2018.04.026.
- 1. Institute of Toxicology, College of Preventive Medicine, Third Military Medical University, Chongqing, PR China.
- 2. Translational Medicine Research Center, School of Pharmaceutical Sciences, Xiamen University, Xiamen, Fujian, PR China.
- 3. Department of Oncology, Southwest Hospital, Third Military Medical University, Chongqing, PR China.
- 4. Nelson Institute of Environmental Medicine, New York University School of Medicine, Tuxedo, New York, 10987, USA.
- 5. Institute of Toxicology, College of Preventive Medicine, Third Military Medical University, Chongqing, PR China. Electronic address: [email protected].
- 6. Institute of Toxicology, College of Preventive Medicine, Third Military Medical University, Chongqing, PR China. Electronic address: [email protected].
Although high mortality of lung Cancer is greatly due to distant metastasis, the mechanism of this metastasis remains unclear. Here, we investigate in lung Cancer that SOX30 is sharply under-expressed in metastatic tumors compared with non-metastatic tumors, and suppresses plenty of metastasis related processes or pathways. SOX30 strongly inhibits tumor cell metastasis in vitro and in vivo. Sox30 deficiency promotes lung metastasis in Sox30-/- mice and this uncontrollable lung-metastasis is re-inhibited upon Sox30 re-expression. Mechanistically, SOX30 diminishes Wnt-signaling via directly transcriptional repressing β-catenin or interacting with β-catenin to compete with TCF for binding to β-catenin. The carboxyl-terminus of SOX30 is required for attenuating β-catenin transcriptional activity, whereas the amino-terminus of SOX30 is required for its interaction with β-catenin protein. Enhance of β-catenin attenuates the anti-metastatic role of SOX30. Moreover, Sox30 deficiency promotes tumor metastasis and reduces survival of mice. In addition, nuclear SOX30 expression is closely associated with metastasis and represents a favorable independent prognostic biomarker of lung Cancer patients. Altogether, these results highlight an important role and mechanism of SOX30 in lung Cancer metastasis, providing a potential therapeutic target for anti-metastasis.